Annual SG&A
$1.63 M
-$366.90 K-18.37%
01 September 2023
Summary:
Bright Minds Biosciences annual selling, general & administrative expenses is currently $1.63 million, with the most recent change of -$366.90 thousand (-18.37%) on 01 September 2023. During the last 3 years, it has fallen by -$181.60 thousand (-10.02%). DRUG annual SG&A is now -18.37% below its all-time high of $2.00 million, reached on 30 September 2022.DRUG Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$234.30 K
-$35.30 K-13.09%
01 June 2024
Summary:
Bright Minds Biosciences quarterly selling, general & administrative expenses is currently $234.30 thousand, with the most recent change of -$35.30 thousand (-13.09%) on 01 June 2024. Over the past year, it has dropped by -$107.80 thousand (-31.51%). DRUG quarterly SG&A is now -67.56% below its all-time high of $722.30 thousand, reached on 30 June 2021.DRUG Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$97.79 M
-$1.86 M-1.94%
01 June 2024
Summary:
Bright Minds Biosciences TTM selling, general & administrative expenses is currently -$97.79 million, with the most recent change of -$1.86 million (-1.94%) on 01 June 2024. Over the past year, it has dropped by -$99.42 million (-6107.14%). DRUG TTM SG&A is now -23311.59% below its all-time high of $2.51 million, reached on 01 March 2022.DRUG TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DRUG Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -31.5% | -6107.1% |
| 3 y3 years | -10.0% | -60.4% | -5447.2% |
| 5 y5 years | - | - | - |
DRUG Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -18.4% | at low | -66.3% | at low | -527.2% | at low |
| 5 y | 5 years | -18.4% | +1813.2% | -67.6% | >+9999.0% | <-9999.0% | at low |
| alltime | all time | -18.4% | +1813.2% | -67.6% | >+9999.0% | <-9999.0% | at low |
Bright Minds Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $234.30 K(-13.1%) | $1.14 M(-4.1%) |
| Mar 2024 | - | $269.60 K(-8.5%) | $1.19 M(-10.9%) |
| Dec 2023 | - | $294.70 K(-13.9%) | $1.34 M(-18.0%) |
| Sept 2023 | $1.63 M(-18.4%) | $342.10 K(+21.0%) | $1.63 M(+0.7%) |
| June 2023 | - | $282.70 K(-32.0%) | $1.62 M(-10.5%) |
| Mar 2023 | - | $415.80 K(-29.2%) | $1.81 M(-4.7%) |
| Dec 2022 | - | $587.30 K(+78.0%) | $1.89 M(-5.4%) |
| Sept 2022 | $2.00 M | $330.00 K(-30.1%) | $2.00 M(-11.5%) |
| June 2022 | - | $472.10 K(-6.6%) | $2.26 M(-10.0%) |
| Mar 2022 | - | $505.40 K(-27.3%) | $2.51 M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $695.30 K(+17.5%) | $2.36 M(+29.2%) |
| Sept 2021 | $1.81 M(+2026.3%) | - | - |
| Sept 2021 | - | $591.50 K(-18.1%) | $1.83 M(+39.7%) |
| June 2021 | - | $722.30 K(+104.4%) | $1.31 M(+118.1%) |
| Mar 2021 | - | $353.40 K(+118.7%) | $600.20 K(+143.1%) |
| Dec 2020 | - | $161.60 K(+125.4%) | $246.90 K(+189.1%) |
| Sept 2020 | $85.20 K | - | - |
| Sept 2020 | - | $71.70 K(+431.1%) | $85.40 K(+523.4%) |
| June 2020 | - | $13.50 K(>+9900.0%) | $13.70 K(+6750.0%) |
| Mar 2020 | - | $100.00(0.0%) | $200.00(+100.0%) |
| Dec 2019 | - | $100.00 | $100.00 |
FAQ
- What is Bright Minds Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly SG&A year-on-year change?
- What is Bright Minds Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bright Minds Biosciences?
- What is Bright Minds Biosciences TTM SG&A year-on-year change?
What is Bright Minds Biosciences annual selling, general & administrative expenses?
The current annual SG&A of DRUG is $1.63 M
What is the all time high annual SG&A for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual selling, general & administrative expenses is $2.00 M
What is Bright Minds Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of DRUG is $234.30 K
What is the all time high quarterly SG&A for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly selling, general & administrative expenses is $722.30 K
What is Bright Minds Biosciences quarterly SG&A year-on-year change?
Over the past year, DRUG quarterly selling, general & administrative expenses has changed by -$107.80 K (-31.51%)
What is Bright Minds Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of DRUG is -$97.79 M
What is the all time high TTM SG&A for Bright Minds Biosciences?
Bright Minds Biosciences all-time high TTM selling, general & administrative expenses is $2.51 M
What is Bright Minds Biosciences TTM SG&A year-on-year change?
Over the past year, DRUG TTM selling, general & administrative expenses has changed by -$99.42 M (-6107.14%)